BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.06 -0.05 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.11 | 52 Week High | $1.63 | |||
| Open | $2.07 | 52 Week Low | $0.71 | |||
| Day High | $2.17 | P/E | N/A | |||
| Day Low | $1.99 | EPS | $0.00 | |||
| Volume | 5,196 | |||||
